IL1B and chronic kidney disease: As shown in Figure 3(G), compared with the blank group, TNF-α, IL-1β, IL-18, and α-SMA increased significantly in the adenine-induced CKD model, while the positive drugs could inhibit TNF-α, IL-1β, IL-18, and α-SMA.